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14 in SVGs, 10 in right coronary arteries and 1 in a protected left main coronary artery. In 
18 pts the covered stents were implanted in de novo lesions and in 7 pts for the treatment 
of in-stent restenosis. The lesion length was 7.7 ± 5.2 mm and the stent length was 17.7 
± 6.1 mm. All pts were discharged under ticlopidine and aspirin for at least 3 months. 
Results. The procedural success rate was 100%. During hospitalization 2 pts had myo- 
cardial infarction (MI); one Q-wave and 1 non-Q-wave MI. Acute or subacute thrombosis 
was not observed. During the clinical follow-up pedod (13.1 ± 11.2 months) 2 deaths 
were encountered and one patient had Ml. Target lesion revascularization was performed 
in 8 lesions. Fourteen pts (56%) were event-free during the follow-up period. Anglo- 
graphic follow-up was performed in 15 pts after 6.1 ± 2.7 months (table). Restenosis of 
the target lesion was observed in 8 lesions (53.3%). Restenosis was focal in 7 lesions 
and diffuse in 1 lesion. The late loss was 1.8 ± 1.5 mm and the loss index was 0.7 ± 0.7. 
Conclusion. The first evaluation of PTFE-covered stents in ostial AC lesions showed that 
the incidence of angiographic and clinical restenosis remains high. 
Table Before Immediately After Follow-up 
Reference Diameter (ram) 3.50 ± 0.63 3.82 ± 0.59 3.50 ± 0.81 
Minimal Lumen Diameter (mm) 1.10 ± 0.60 3.68 ± 0.63 1.89 ± 1.32 
Stenosis (%) 69.99 ± 14.75 3.31 ± 8.72 47.89 ± 34.72 
phology before RA was significantly higher than that of non-diabetics in the follow-up 
period (41% vs 13%; p<0.05). Conclusions: We conclude that RA is not effective for 
ostial stenosis in diabetics compared with non-diabetics 
DM (n=25) Non-DM (n=30) 
ACC/AHA Type B2 19 (63%) 19 (63%) 
Type C 7 (23%) 7 (23%) 
Lesion length(mm) 9.86±7.90 9.47±8.48 
Reference (mm) 2.90±0.53 3.01±0.47 
MLD (mm) 0.86±0.39 0.95±0.44 
Before 
After 2.80±0.71 2.86±0.57 
Burr/Artery ratio 0.70±0.11 0.69±0.10 
Resenosis (%) 14/17 (61%) 9/23 (39%)* 
Progression (%) 7/17 (41%) 3/23 ( 13%)** 
*:p<0.01 **:p<0.05 
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1195MP-123 Effect  o f  Stenting on the Instantaneous Diastolic Flow 
Velocity: Pressure Gradient  Relat ion in Pat ients  With a 
Severe Coronary  Stenosis 
Koen M. Maroues, H. J. Spruijt, N. Westerhof, C. A. Visser, E C. Visser, VU Medical 
Center, Amsterdam, The Netherlands, ICarVU, Amsterdam, The Netherlands. 
In the cath lab, the significance of a coronary stanosis can be assessed by the coronary 
flow reserve (CFR) or the fractional flow reserve (FFR). Each of these techniques how- 
ever has limitations. In animals, the instantaneous diastolic flow velocity - pressure gradi- 
ent (v-dp) relation has been demonstrated to express accurately the hemodynamic 
impact of coronary stenoses. Data in humans are rare. In this study we examined the 
effect of a coronary stenosis and the effect of stenting on the v-dp - relation in 7 patients. 
A Doppler wire and a pressure wire were positioned distal to the coronary stenosis. After 
administration of adenosine the instantaneous flow velocity, the proximal and distal coro- 
nary pressure were recorded digitally (sample frequency 100Hz). For each coronary 
artery the middiastolic v-dp data of one cardiac cycle at maximal and intermediate hyper- 
emia and at baseline were plotted on an X-Y scatter plot. A regression line was calcu- 
lated using the equation: y=ax+bx 2"In all patients stanting was performed successfully. 
The mean diameter stenosis before PTCA was 70% and was reduced to 5% after stent- 
ing. The v-dp relation was reassessed after PTCA. The mean v-dp curves (± 1 SD) of all 
stenoses before PTCA and after stenting are shown in the figure. 
Conclusion: the instantaneous diastolic flow velocity - pressure gradient relation gives a 
clear quantitative description of the hemodynamic impact of a coronary stenosis in which 
both pressure and flow characteristics are incorporated. 
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Comparison of Results of Rotational Atherectomy for 
Coronary Ostial Stenosis In Diabetics Versus 
Nondiabetics 
Koichi Kishi. Yoshikazu Hiasa, Koji Yamaguchi, Kensuke Fujiwara, Riyo Ogura, 
Yoshikazu Ohars, Teru Nade, Kenichiro Yuba, Kanji Kusunoki, Tatsuro Ogata, Takefumi 
Takahashi, Shinobu Hosokawa, Ryuji Otani, Tokushima Red Cross Hospital, 
Komatsushima, Japan. 
Background: The object of this study is to investigate the efficacy of rotational atherec- 
tomy (RA) for coronary artery ostial stenosis in diabetic patients.. Methods: A consecu- 
tive series of 55 patients with ostial stenosis who underwent RA were the subject of 
study. These patients were divided into diabetic and non-diabetic patients. Results: 
There were no significant differences between the two groups in terms of baseline clinical 
characteristics, lesion characteristics, and procedural factors. The restenosis rate of dia- 
betic patients was significantly higher than that of non-diabetic patients by the 6-months 
angiogram (61% vs 39%; p<0.01). The rate of progression compared with lesion mor- 
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1195MP-125 Predictors of Adverse In-Hospital Events Following 
Percutaneous Coronary Revascularization In the 
Currant Era: A Report From the NHLBI Dynamic 
Registry 
Javier Jimenez. Janet Johnston, Peter Block, Gianni Amato, Sheryl Kelsey, Howard 
Cohen, Katherine Detre, David O. Williams, Dynamic Registry Investigators, Rhode 
/s/and Hospital, Brown Universi~ Providence, Rhode/s/and. 
Background: Although stents and antithrombotic agents have enhanced the safety and 
effectiveness of percutaneous coronary intervention (PCI), in-hospital death and myocar- 
dial infarction (MI) are still observed. In an attempt to reduce the incidence of these 
adverse events further, we sought to identify those factors associated with their occur- 
rence. Methods: In-hospital outcomes and baseline and procedural characteristics were 
analyzed among 4629 patients (pts) enrolled in 17 centers within the NHLBI Dynamic 
Registry. To detect the influence of evolving therapies and techniques, patients were 
included from two enrollment waves, 1997-98 and 1999. Multivadable models were 
developed from a universe of variables potentially associated with death or death and MI. 
Results: Death occurred in 69 pts (1.5%) and death/MI in 191 pts (4.1%). Independently 
associated variables for death included total occlusion attempted (Odds Ratio 2.2, 95% 
95% Confidence Interval 1.2-4.1 ), increasing age (1.1, 1.0-1.1 ), history of CHF (2.7, 1.4- 
5.3), renal failure (3.5, 1.6-7.8), attempted vessel supplies collaterals (2.5, 1.0-6.1), car- 
diogenic shock 10.6, 4.9-22.7), >2 lesions attempted (3.0, 1.3-7.0), emergency proce- 
dure 8.9 (3.8-21.0) and urgent procedure (2.8, 1.3-6.2). When the combined endpoint of 
death/MI was analyzed, evidence of thrombus (1.8, 1.3-2.6) and peripheral vascular dis- 
ease (1.7, 1.1-2.7) were positively associated while use of ticlopidine (0.6, 0.4-0.9) had a 
protective effect. Neither stents nor planned use of Ilbllla antagonists had a protective 
effect and MI as an indication for PCI did not increase risk. Conclusion: Multiple factors 
were associated with death or death/Ml. The presence of extreme hemodynamic impair- 
ment at procedure outset was most influential while advanced age, renal failure and 
peripheral vascular disease were other contributing baseline variables. Attempting a total 
occlusion, presence of thrombus, a vessel that supplies collaterals or more than one 
lesion are variables that should be considered when selecting pts for PCI or in planning 
procedural strategies. 
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1195MP-126 Hemodynamic  Impact  of  Severe Coronary Stenoses In 
Pat ients  With and Without a Prior Myocard ia l  In farct ion  
Koen M. Maroues, H. J. Spruijt, J. G. Bronzwaer, N. Westerhof, C. A. Visser, F. C. Visser, 
VU Medical Center, Amsterdam, The Netherlands,/Car-VU, Amsterdam, The 
Netherlands. 
Background: In normal myocardial regions, the accuracy of a frectional flow reserve 
(FFR) value of 0.75 and a coronary flow velocity reserve (CFVR) value of 2.0 to identify 
significant coronary stenoses has been established. In partially infarcted regions, the 
mass of viable myocardium depending on the infarct related artery is smaller and resis- 
tive vessels may be dysfunctional; therefore it remains unknown whether the FFR and 
CFR cut-off varues are applicable in IRA's. 
Methods and Results: In this study we compared the CFVR and FFR in 6 IRA's with 
residual ischemia at SPECT MIBI with 7 IRA's without residual ischemia and 18 non- 
IRA's with ischemia. All patients in the 3 groups had a similar degree of a epicardial 
stenosis. All infarctions occurred at least 4 weeks before the measurements. The CFVR 
and FFR were measured simultaneously with a Doppler wire and a pressure wire, after 
intracoronary administration of adenosine. In contrast to the IRA's without residual 
ischemia, we found in the IRA's with residual ischemia FFR and CFVR values lower than 
the established cutoff values. 
Conclusion: these data indicate that the 0.75 and 2.0 cut-off values of FFR and CFVR 
are applicable in patients with a prior myocardial infarction. The hemodynamic impact of 
a severe coronary stenosis depends on the amount of (residual) ischemic myocardium. 
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non-IRA IRA with residual IRA without residual 
ischemia ischemia 
n 18 6 7 
% diameter stenosis 70¢7 69±10 64±7 
FFR 0.57±10 0.70±0.08 0.83±0.04 
CFVR 1.58±0.53 1.21±0.22 2.62±0.67 
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1195MP-127 Impact  of  Srnok lng  Habit  on Cl inical  Outcomes  Af ter  
Percutaneous Coronary In tervent ion  
Dale T. Ashbv. G. Dangas, M Farkouh, I. lakovou, G. Weisz, I. Hjazi, M Adamian, E. 
Aymoog, M. Mohamed, R. Mehran, G. W. Stone, A. J. Lansky, M. Collins, J. Moses, M B. 
Leon, Cardiovascular Research Foundation, New York, New York, Lenox Hill Heart and 
Vascular Institute, New York, New York. 
Background: A smoker's paradox has been described after thrombolysis and PCI in 
acute MI, as the unadjusted early and late mortality of current smokers is low. The long- 
term prognostic implications of smoking at the time of PCI in the non-acute MI setting is 
unclear. 
Methods: Between 1994 and 1999, 5,592 consecutive pts underwent successful PCI of 
de novo lesions in native coronary arteries in a single center. Event-free survival was 
examined and stratified by smoking status at the time of intervention (1,025 current 
smokers, 2,155 ex-smokers and 2,412 nonsmokers). 
Results: Baseline characteristics between the non smokers and ex-smokers were simi- 
lar. In contrast, current smokers, compared to either the ex- or non smokers, were 
younger (mean age 57 + 11 yrs vs. 65 +- 11 yrs vs. 66 +_ t l  years respectively, p<0.O001) 
and had lower rates of diabetes meilitus (21% vs. 30% vs. 31%, p<O.O001) and lower 
rates of hypertension. The adjusted odds ratios (OR) and 95% confidence intervals (CI) 
of the adverse events in-hospital and at one year for the current and ex-smokers relative 
to the non smokers are shown in the table. 
Non Smoker  Ex-Smokar Current smoker 
(n=2,412) (n=2,155) (n=1,025) 
OR OR [95% Cl], P OR [95% Cl], P 
In-hospital 
Death 1.0 0.58 [0.37-0.89], p=0.01 0.50 [0.22-1.13],p=0.10 
MI 1.0 1.00 [0.89-1.14], p=0.96 1.22 [1.04-1.43], p=0.02 
TLR 1.0 0.84 [0.56-1.25], p=0.39 0.71 [0.41-1.24], p=0.23 
1 -year: 
Death 1.0 1.0 [0.83-1.21], p--0.99 1.46 [1.12-1.90], p=0.006 
MI 1.0 1.11 [0.67-1.85], p=0.68 1.45 [0.80-2.63], p=0.23 
TLR 1.0 1.02 [0.91-1.15], p=0.68 0.87 [0.74-1.02], p=O.09 
Conclusions: Previous smokers who quit prior to PCI have similar prognosis to pts who 
never smoked. In contrast in-hospital MI and 1-year mortality after PCI is significantly 
increased in active smokers despite their more favorable baseline risk profile. These data 
emphasize the favorable impact of discontinuing smoking on long-term clinical outcome 
after PCI. 
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1195MP-128 Card iac  Rehabi l i tat ion Part ic ipat ion Decreases  the  
Need for Target Vessel Revaeculadzatlon Following 
Percutaneous Coronary In tervent ion  
Maiid M. Alzaooum. Adnan Afzal, Husam Noor, Clinton Browner, Rajesh Surapaneni, 
Henry Kim, Staven Ketayian, Henry Ford Hospital, Detroit, Michigan. 
Background: Participation in Cardiac rehabilitation (CR) after myocardial infarction has 
been demonstrated previously to decrease mortality and morbidity. Only a few studies with 
small numbers of patients have investigated the potential beneficial effects of CR following 
percutaneous coronary intervention (PCI) 
Methods : We analyzed retrospective data on 525 consecutive patients who underwent 
PCI at Henry Ford hospital (HFH) from 6/98-2/99. We were able to obtain 6-months follow- 
up on 501 patients. 120 of those patients participated in the CR program at HFH and 381 
did not. All baseline demographic and clinical variables were similar between the CR and 
non-CR group except race and presence of pre-PCI TIMI flow 0. The CR group had 35% 
African American, non-CR group 20%, p=0.004. The CR group had pre-PCI TIMI flow 0 
28.4%, non-CR group 18.6%, p=0.04. 
Results : Rate of Target vessel revascularization (TVR) was significantly lower in the 
patients participating in CR (12.5%) vs. the non-CR group (20.7%), p--0.037, odds ratio 
(OR) 0.55. There was no significant difference in the need for re-hospitalization between 
the CR and non-CR group. Analysis of independent variables associated with TVR and the 
need for re-hospitalization was significant for female gender (p=0.046, p=0.016) and graft 
disease (p=O.04, p=0.045). Multivariate logistic regression analysis using a selection rule of 
p<0.25 revealed a significant difference for rate of TVR between the CR and non-CR group 
(p=0.049, OR 0.55) and for female gender p=0.043, OR 1.16). Female gender was also 
significantly associated with the need for re-hospitalization (p=0.015, OR 1.61) 
Conclusion : This non-randomizes retrospective study suggest a significant benefit of par- 
ticipating in CR following PCI with a significant decrease in the need for TVR at 6-month 
follow p. A large prospective randomized clinical trial is necessary to confirm this important 
finding. 
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1195MP-129 Long-Term Follow-Up After Coronary Angloplasty in 
Young Patients (<40 Years of Age) 
Remi Choussat. Alexander Black, Jean-Pierre Laurent, Bernard Cassagneau, Bruno 
Farah, Jean Fajadet, Jean Marco, Unite de Cardiology Interventionnalle, Clinique 
Pasteur, Toulouse, France. 
Background: Young patients are now commonly treated by percutaneous coronary inter- 
vention (PCI). However, there is little information available conceming the results of the 
procedure. The purpose of this single center study was to evaluate the long-term out- 
come of PCI in young adults. 
Methods: Between July1995 and July 1999, 103 consecutive patients younger than 40 
years of age (men: 98 cases; mean age 36.9±2.0 years) were treated by PCL These 
patients comprised 1.3% of 8181 patients who underwent PCI during this period in our 
institution. Demographic, clinical and procedural predictors of survival and event-free 
survival, defined as freedom from death, myocardial infarction (MI), coronary revascular- 
iation (target vessel ('I'VR) and any coronary revascularisation) were analyzed. Follow-up 
(mean duration 30.2±12.1 months) was obtained in all patients. 
Results: At admission, 14 patients had stable angina, 45 had unstable angina and 36 had 
recent MI (< 1 month). Coronary risk factors were smoking in 94 cases, history of hyper- 
cholestarolemia in 48, systemic hypertension in 14 and diabetes meilitus in 6. One vessel 
disease was found in 52 patients and 3 vessel disease in 15. Mean left ventricular ejec- 
tion fraction was 63±5%. Stent implantation was performed in 67 cases. Primary success 
was obtained in 102 patients. At follow-up no patient died, 2 had MI and 22 underwent 
repeat coronary revascularization (14 target vessel revascularization and 13 non-target 
vessel revascularization). The estimated 3-year event-free survival (freedom from death/ 
MI and freedom from deeth/MI/target and non-target vessel revasculadzation) were 
(meen±SE) 98.0±1.3% and 76.6±5.1%. At end of follow-up, 18 patients were still current 
smokers, 83 were on lipid lowering therapy and 89 patients were free of angina. No factor 
was found to be predictive of cardiac events in uni- or multivariate statistical analysis. 
Conclusion: Early and late results after PCI in young adults (< 40 years of age) are favor- 
able in terms of survival despite the need of repeat procedures due to restenosis and 
progression of atherosclerotic coronary artery disease in non target vessel. 
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11 95MP-130 Long-Term Outcome After Long Les ion  (>25 ram) PCI in 
390 Consecutive Patients: A Single  Center  Experience 
Remi Choussat, Catherine Klersy, Alexander Black, Bernard Cassagneau, Jean-Pierre 
Laurent, Christian Jordan, Jean Fajadet, Jean Marco, Unite de Cardiology 
/nterventionna//e, Toulouse, France. 
Background: PCI of long coronary lesion is now common practice, however, there is little 
information available concerning long-term follow-up. The purpose of this single-center 
study was to evaluate the long-term outcome of PCI for long lesions in a large consecu- 
tive series of patients. 
Methods: Between May 1995 and December 1998, 390 consecutive patients with long 
coronary lesion (> 25 mm length; mean lesion length: 34 ± 10 ram) underwent PCI. 
These patients comprised 5.3% of 7336 patients who underwent PCI during this period in 
our institution. Demographic, clinical and procedural predictors of survival and event-free 
survival, defined as freedom from death, myocardial infarction (MI), coronary revascular- 
iation (target vessel (TVR) and any coronary revascularisation) were analyzed. 
Results: Follow-up (mean 30±10 months) was obtained in 385 pts (98.7%). Stent implan- 
tation was performed in 239 patients (61%) with more than 1 stent in 36 cases (15.9%). 
Saphenous vein graft PCI was performed in 76 patients (19.5%). Primary success was 
obtained in 378 cases (96.9%). The 3-year event-free survival (freedom from death, free- 
dom from death/MI/TVR and freedom from death/MI/any coronary revascularization) 
were (meen±SE) 91 ± 1%, 70 ± 2% and 64 ± 3% respectively. Lower left vantricular ejec- 
tion fraction was found to be an independent predictor of death during follow-up (HR, 
95%C1:0.12 (0.01-1.0); p=0.05). At 3-year follow-up, freedom from TVR and any coro- 
nary revascularization were 77 ± 2% and 72 ± 2% respectively. Single stent implantation 
was found to be an independent predictor of TVR (HR, 95%C1:0.32 (0.11-0.96); p=0.04). 
Neither lesion length, nor stent implantation, nor stented segment length were found to 
be independent predictors of cardiac events at follow-up. 
Conclusion: This study provided a useful assessment of long-term outcome in terms of 
survival, event-free survival and predictors of major cardiac events after long lesion PCI. 
